Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 2, 2026

Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model
07:29

Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model

Published on: September 27, 2024

Animal models with pathological mineralization phenotypes.

Uwe Kornak1

  • 1Institute for Medical Genetics and Human Genetics, Charité-Universitaetsmedizin Berlin, Berlin, Germany. uwe.kornak@charite.de

Joint Bone Spine
|May 10, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 3D Human Bone and Bone Marrow-on-a-Chip Model for In Vitro Bone Remodeling and Immune Cell Maintenance.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Romosozumab is effective in patients with variants in LRP5, LRP6, or WNT1.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Autosomal Dominant Osteopetrosis - Identification of a New Mutation.

European journal of case reports in internal medicine·2026
Same author

Genotype-based comparison of bone microstructure in adult patients with classical osteogenesis imperfecta.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Autosomal recessive hypophosphatemic rickets type 2 (ARHR2): Is phosphate supplementation safe?

Bone·2025
Same author

A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia.

Nature·2025
Same journal

Greater trochanteric bursal distension with intra-bursal rice bodies: an unusual MRI presentation.

Joint bone spine·2026
Same journal

Evaluating the Impact of a Rheumatologist-led Comorbidity Review in Patients with Inflammatory Arthritis.

Joint bone spine·2026
Same journal

What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.

Joint bone spine·2026
Same journal

Multimodal imaging evaluation of the entheses in spondyloarthritis.

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?

Joint bone spine·2026
See all related articles

Mineralization inhibitors like fetuin-A and pyrophosphate are crucial for preventing ectopic calcification. Mouse models reveal specific roles of these inhibitors in preventing tissue dysfunction and associated pathologies.

Area of Science:

  • Biomineralization
  • Skeletal Biology
  • Pathology

Background:

  • Extracellular matrix mineralization is vital for skeletal integrity and mineral homeostasis.
  • Dysregulated mineralization, or ectopic calcification, can lead to tissue dysfunction and disease.
  • Key inhibitors include fetuin-A, matrix Gla-protein (MGP), SIGBLING proteins, and pyrophosphate.

Purpose of the Study:

  • To summarize findings from mouse models regarding the role of mineralization inhibitors.
  • To elucidate the regulation of mineralization-promoting factors in pathological conditions.
  • To understand the specific patterns of ectopic mineralization upon loss of inhibitors.

Main Methods:

  • Analysis of mouse models exhibiting pathological mineralization phenotypes.

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

High-Throughput, Multi-Image Cryohistology of Mineralized Tissues
10:18

High-Throughput, Multi-Image Cryohistology of Mineralized Tissues

Published on: September 14, 2016

Related Experiment Videos

Last Updated: Jun 2, 2026

Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model
07:29

Comprehensive Characterization of Tissue Mineralization in an Ex Vivo Model

Published on: September 27, 2024

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

High-Throughput, Multi-Image Cryohistology of Mineralized Tissues
10:18

High-Throughput, Multi-Image Cryohistology of Mineralized Tissues

Published on: September 14, 2016

  • Investigation of the roles of specific mineralization inhibitors (fetuin-A, MGP, etc.).
  • Examination of the regulation of mineralization-promoting factors.

    • Main Results:

    • Loss of specific inhibitors leads to distinct patterns of ectopic mineralization, not generalized calcification.
    • Pathological mineralization commonly affects connective tissues, cartilage, and vasculature.
    • Mouse models provide insights into the mechanisms underlying degenerative joint disorders and arteriosclerosis.

    Conclusions:

    • Mineralization inhibitors play critical, specific roles in preventing ectopic calcification.
    • Maintaining a balance between inhibitors and promoters is essential for tissue health.
    • Understanding these mechanisms in mouse models aids in comprehending human pathologies like arthritis and atherosclerosis.